🥗 Can diet impact #RheumatoidArthritis? 🥩 New study finds: ✅A low-carbohydrate diet (LCD) may reduce #RA risk. ✅High protein intake is linked to a lower likelihood of RA. 🔗 rdcu.be/d30wH #Diet

🌟 A New Era for Clinical Rheumatology! We are excited to share the first editorial by our Editor-in-Chief, Prof. Adewale Adebajo, marking a new chapter for the journal. "Together, we advance research, education, and innovation in rheumatology worldwide!"

🎄 Thank you to our readers, authors, and reviewers for your invaluable contributions this year. Your dedication helps us advance the field of #rheumatology and improve patient care worldwide. Wishing you a joyful holiday season and a successful New Year! 🌟❄️🎄

New Study Highlights Urgent Need for #Rheumatology #Education in Medical Schools. 🔍 Teaching hours: 4–120 globally 📉 Limited exposure impacts awareness & recruitment 📚 Standardized curricula needed for rising rheumatic disease burden bit.ly/4gL4khX

Take a look at the January issue of Clinical Rheumatology! Explore the newest articles and updates. 👉bit.ly/4fW4Jgi

🔥New Editorial to read! 👉rdcu.be/d67Ug Explore strategies for tailored #PatientEducation to boost adherence, improve outcomes, and tackle challenges in biologic therapy. #biologics #rheumatology

🔥NEW🔥 Refractory #PsoriaticArthritis: emerging concepts in whole process management 👉rdcu.be/d674F 📌Phases of #PsA development and strategies for prevention 👇

Refractory #PsoriaticArthritis #PsA: 🔍 Lack of consensus on definition. ✅ Authors propose two categories: 📌D2T PsA: persistent despite treatment. 📌Pseudo-D2T PsA: misdiagnosis or mismanagement. Clear distinctions can improve care! 👉rdcu.be/d674F

📢 New Review on Ectopic Calcifications in the Musculoskeletal Field ✅ Mechanisms of soft-tissue calcifications ✅ Pharmacological strategies: NSAIDs, corticosteroids, bisphosphonates, vitamin K2+D ✅ Balancing #calcification inhibition with bone health 👉rdcu.be/d7HdC

How do ILAR & PRINTO classifications impact #JIA diagnosis and treatment? 👉tiny.cc/o688001 ✅Age & ANA positivity (≥1/160) improve consistency in assessing uveitis risk & treatment response ✅One positive ANA test may be enough—no need for repeat testing ✅ Early

Take a look at the February issue of Clinical Rheumatology! Explore the newest articles and updates 👉link.springer.com/journal/10067/…

Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup? 👉rdcu.be/d9uzU 📊 Key findings from the Reuma-check cohort: ✔️ 28% of axSpA cases started at ≥45 years. ✔️ More common in females (51%) & psoriasis (42%). ✔️ Lower NSAID response (52%) & HLA-B27 positivity (32%). ✔️

Late-onset #AxialSpondyloarthritis #AxSpA: data from Reuma-check cohort by Rodrigo G Salinas and colleagues Sofia Ramiro 👉doi.org/10.1007/s10067…

Take a look at the March issue of Clinical Rheumatology! Explore the newest articles and updates 👉link.springer.com/journal/10067/…

A disproportionality analysis of FAERS data (2012–2022) reveals distinct safety profiles of #JAKinhibitors in #RheumatoidArthritis: 🔴 Baricitinib → Highest risk for CV events & cancer 🟠 Upadacitinib → ⬆️risk for respiratory & GI events 🟢 Tofacitinib → Lower cancer risk but

📚 New review article Ectopic #calcifications in tendons, ligaments & muscles present clinical challenges in rheumatology. This study outlines pharmacological strategies for prevention & treatment, including NSAIDs, bisphosphonates, and vitamin K2 + D. 👉rdcu.be/efIPz

Take a look at the April issue of Clinical Rheumatology! Discover the latest research and insights in the field. 👉link.springer.com/journal/10067/…

🧬Can #CARTcells therapy revolutionize treatment for refractory autoimmune diseases? 👉rdcu.be/elAeK This new review explores its potential in SLE, RA, SSc, Sjögren’s & more, with early data showing long-term remission in severe cases.

🧐Have you checked out the May issue of Clinical Rheumatology? link.springer.com/journal/10067/… 🔹 Tackling health inequalities in rheumatology 🔹 "PsAI" – AI in psoriatic disease 🔹 Gut–joint axis in JIA 🔹 Bioimpedance in OA diagnosis 🔹 Acupuncture in Sjögren’s and much more!!